LACTATE DEHYDROGENASE (LDH) - ANVISA Registration 81313770071
Access comprehensive regulatory information for LACTATE DEHYDROGENASE (LDH) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81313770071 and manufactured by MEDMAX COMÉRCIO DE EQUIPAMENTOS MÉDICOS E SIMILARES LTDA ME. The registration is held by MEDMAX COMÉRCIO DE EQUIPAMENTOS MÉDICOS E SIMILARES LTDA ME with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81313770071
25351065665202576
07760277000323
Company Information
Dates and Status
Jun 09, 2025
VIGENTE
09/18/2025 19:00:01
LACTATO DESIDROGENASE (LDH)
DESIDROGENASE LÁTICA LDH AUTOMAÇÃO - LINHA DT
DAILYTECH LATINO AMERICA LTDA
80657030080
May 05, 2025
LACTATO DESIDROGENASE (LDH)
FAMÍLIA LDH
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390281
Feb 17, 2025
LACTATO DESIDROGENASE (LDH)
LDH-L SL
DAILYTECH LATINO AMERICA LTDA
80657030049
Dec 23, 2024
LACTATO DESIDROGENASE (LDH)
HORIBA POINTE LACTATE DEHYDROGENASE
HORIBA INSTRUMENTS BRASIL LTDA
10347320370
Sep 04, 2023
LACTATO DESIDROGENASE (LDH)
HORIBA POINTE LACTATE DEHYDROGENASE
HORIBA INSTRUMENTS INCORPORATED
10347320370
Sep 04, 2023

